FAFTFSNP
JAZZ icon

Fjarde AP-fonden (The Fourth Swedish National Pensionfund)’s Jazz Pharmaceuticals JAZZ Stock Holding History

Fjarde AP-fonden (The Fourth Swedish National Pensionfund)’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$216K Buy
+2,020
New +$222K ﹤0.01% 518

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Fjarde AP-fonden (The Fourth Swedish National Pensionfund)'s JAZZ Position: Q2 2024 in Review

Fjarde AP-fonden (The Fourth Swedish National Pensionfund) opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2024: 2,020 shares worth $216K. The stake represents ﹤0.01% of the portfolio and ranks #518 among its holdings.

456 funds tracked by Wall St. Rank hold JAZZ as of Q2 2024.

  • Fjarde AP-fonden (The Fourth Swedish National Pensionfund) held 2,020 shares of Jazz Pharmaceuticals worth $216K as of Q2 2024.
  • Jazz Pharmaceuticals was a new Fjarde AP-fonden (The Fourth Swedish National Pensionfund) position in Q2 2024.
  • Jazz Pharmaceuticals made up ﹤0.01% of Fjarde AP-fonden (The Fourth Swedish National Pensionfund)'s portfolio in Q2 2024, its #518 holding.
  • 456 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2024.

Based on Fjarde AP-fonden (The Fourth Swedish National Pensionfund)'s 13F filing for Q2 2024, filed 2 Aug 2024.